Pancreatic cancers are characterized by high levels of inflammatory cells and profound immune suppression. In this issue of Cancer Cell, Bayne et al. and Pylayeva-Gupta et al. show that KRAS-driven, tumor cellsecreted GM-CSF recruits myeloid-derived suppressor cells to the stroma to abrogate tumor cell immune clearance by killer T lymphocytes.
Soldiers in the army of immune surveillance may fight on the side of the host or may be be co-opted to fight on the side of the tumor. Host immune surveillance is thought to be important to limit both cancer development and cancer progression (Schreiber et al., 2011) , whereas failure may be due to a countervailing local immunosuppression mediated by the tumor.
Pancreatic ductal adenocarcinomas (PDA or PDAC) are among the deadliest cancers, notable for their aggressiveness, profound immunosuppression, and remarkable degree of desmoplasia surrounding the nests of ductal epithelial cells (Clark et al., 2007) . Tumor cells are encased in a high-pressure, fibrous stromal mass composed of a dense extracellular matrix and of fibroblasts, pancreatic stellate cells, endothelial cells, nerve cells, and large numbers of inflammatory cells, especially of immature myeloid lineages. This intricate stromal remodeling in PDAC is also distinguished by the conspicuous absence of T lymphocytes.
Inflammation leading to PDAC desmoplasia depends on paracrine signals produced by neoplastic epithelial cells, a process largely driven by oncogenic KRAS, which is mutated in essentially all human PDAC (Jones et al., 2008) . Indeed, acute loss of mutant KRAS in established pancreatic tumors results in rapid quiescence and involution of pancreatic tumor stroma (Collins et al., 2012 Figure 1 ) (Bayne et al., 2012; Pylayeva-Gupta et al., 2012) . Several themes emerged from these investigations: (1) a key role for KRAS in driving the inflammatory tumor microenvironment, beginning early in pancreatic intraepithelial neoplasia (PanIN) development and continuing through frank carcinoma; (2) the critical and surprisingly specific importance of GM-CSF; (3) the dependence of both emerging and established PDAC on GM-CSF-responsive MDSCs recruited to the pancreatic stroma; and (4) the failure of CD8 cytotoxic T cell immunity unless either GM-CSF or MDSCs was disrupted. An important strength of these complementary reports is their use of genetically engineered mouse strains that express the oncogenic KRAS G12D from the endogenous KRAS locus specifically in the pancreas (Hingorani et al., 2005 (Hingorani et al., 2005) . This model faithfully recapitulates the pathophysiological characteristics of different stages of human PDAC. Bayne et al. (2012) (Bayne et al., 2012) . Near-complete abrogation of GM-CSF mRNA upon pharmacological inhibition of MEK or PI3K in KRAS-PDEC demonstrated that the Ras/MAPK and PI3K effector pathways regulate GM-CSF in these cells at the level of transcription (Pylayeva-Gupta et al., 2012) .
How do we know that KRAS-mediated escape from T cell immunity is important? First, no CD8 T cells were present in nascent orthotopic tumors established from KRAS G12D -PDECs, whereas tumors established from shKRAS G12D -PDECs displayed a CD8 cell infiltrate and underwent apoptosis at 2 weeks after implant (Pylayeva-Gupta et al., 2012) . These results suggest that CD8 cytotoxic T cells can recognize and clear incipient PDAC tumors, but that KRAS signaling is able to overcome that clearance. The extensive secretion of GM-CSF suggested that this cytokine plays a central role: disrupting GM-CSF secretion or neutralizing its activity inhibited tumor growth and maintenance. Conversely, depleting CD8 could rescue tumor growth impaired by loss of GM-CSF.
What are the origins of myeloid-derived immune suppressor cells in PDAC? The growth of KPC-derived PDAC was dependent upon Gr1 + CD11b + cells, which showed hallmarks of MDSCs, namely increased levels of arginase and iNOS (Bayne et al., 2012) . iNOS played an important role in suppressing antigen-specific proliferation of T cells. The MDSCs were derived from c-kit + splenic precursors (Bayne et al., 2012) , which proliferated and differentiated in response to conditioned medium from PDAC cells or to GM-CSF. Their maturation from bone marrow-derived Gr1 À CD11b À cells, recruitment, and immune-suppressing ability required GM-CSF. Collectively, these results support the existence and importance of a GM-CSF-driven paracrine immune suppression circuit in PDAC.
Many complexities remain to be unraveled. The great Yogi Berra famously said, ''When you come to a fork in the road, take it.'' The winning side of the war on pancreatic cancer may be determined in part by fork control: whether CD8 soldiers are battling for the host or are run off the battlefield by the tumor. 
